1.23
Valion Bio Inc Aktie (VBIO) Neueste Nachrichten
Valion Bio, Inc. (VBIO) Stock Price & News - Syfe
Form PRE 14A Valion Bio Inc For: 12 October By Investing.com - Investing.com India
A potential radiation drug could be absorbed through the mouth instead of injected. - Stock Titan
Valion Bio Secures Additional Series B Preferred Financing - The Globe and Mail
Up to $5M in stock is included in Valion Bio (NASDAQ: VBIO)'s proposed securities offering. - Stock Titan
About $35.6 million in U.S. funding supports Valion's experimental drug for radiation sickness - Stock Titan
Valion Bio Announces Completion of Entolimod Oral Mucosal Formulation Development - kalkinemedia.com
If developed and authorized or approved, a needle-free radiation drug could have ~10–40x the dose potential of injections. - Stock Titan
Form 4 Valion Bio Inc For: 24 September - Investing.com India
Form 4 Valion Bio Inc For: 24 September By Investing.com - Investing.com Canada
A 50,000-unit award for Valion Bio (VBIO) interim CEO Zikria Dean is set to start vesting December 22. - Stock Titan
After a 1-for-25 reverse stock split, Valion Bio (VBIO) executive reports a stock-unit settlement. - Stock Titan
A former Pfizer strategist is Valion Bio's interim CEO - Stock Titan
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule - The Globe and Mail
Valion Bio's shares met Nasdaq's $1 minimum. The listing matter is closed. - Stock Titan
Valion Bio Insider Report Highlights Jensen Thomas as Director, Ticker VBIO - Kalkine Media
Inmune Bio (NASDAQ: INMB) grants 100,000 stock options to new director - Stock Titan
Valion Bio (VBIO) director reports zero share stake - Stock Titan
Investor group in Valion Bio (VBIO) shifts to passive stake - Stock Titan
Valion Bio Announces Changes to Management and Board of Directors - ACCESS Newswire
3i's $16.3M note in Valion Bio (VBIO) carries a 9.99% cap - Stock Titan
Aberdeen Income Credit Strategies Fund (ACP-PA) Peer Comparison – Compare with Others - Value Research
3i invests $7.7M in Valion Bio (VBIO) via preferreds and warrants - Stock Titan
Valion Bio appoints CFO Lisa Wolf as president, COO - TipRanks
Valion Bio's Ownership Structure Based on 32,140,634 Shares Outstanding (NASDAQ: VBIO) - kalkinemedia.com
Valion Bio Expands Lisa Wolf’s Role, Adds Two Board Directors - citybiz
Valion Bio names Lisa Wolf president and COO, adds directors - Investing.com
Valion Bio names Lisa Wolf president and COO, adds directors By Investing.com - Investing.com Nigeria
Valion Bio names Lisa Wolf president and COO, adds directors By Investing.com - Investing.com UK
Valion Bio Announces Changes to Management and Board of Directors - The Globe and Mail
Valion Bio raises capital via new preferred financing - TipRanks
Valion Bio appoints Jared Malbin and Thomas Jensen to its board - TradingView
Valion Bio names Lisa Wolf president and COO, adds directors By Investing.com - Investing.com India
Valion Bio Raises $7.74 Million Via Series B/C Preferred and Warrants From 3i - TradingView
Valion Bio, Inc. Common Stock (VBIO) Financials 2026Income Statement and Balance Sheet - MarketBeat
Valion Bio Inc (VBIO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
3i group holds sub-10% Valion Bio (VBIO) stake with warrants, note - Stock Titan
Valion Bio, Inc. (VBIO) Stock Price & News - Syfe
Valion Bio Inc (VBIO) Peer Comparison – Compare with Others - Value Research
Valion Bio Announces 1-for-25 Reverse Stock Split to Regain Nasdaq Compliance - Minichart
Valion Bio announces 1-for-25 reverse stock split By Investing.com - Investing.com Nigeria
Valion Bio announces 1-for-25 reverse stock split By Investing.com - Investing.com India
Valion Bio announces 1-for-25 reverse stock split By Investing.com - Investing.com UK
Valion Bio Announces Reverse Stock Split - ACCESS Newswire
News by ACCESS Newswire on TradingView, 2026-08-27 - TradingView
Valion Bio Announces Reverse Stock Split - Yahoo Finance
Valion Bio announces 1-for-25 reverse stock split - Investing.com
Valion Bio (VBIO) holder nears 10% after big preferred swap - stocktitan.net
Valion Bio, Inc. SEC Filing (Aug 24, 2026) - Stock Titan
3i injects cash into Valion Bio (VBIO) under tight ownership cap - Stock Titan
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):